Table 9 Eighty-two HTLV-1-positive liver transplantation cohort in Japan by Yoshizumi et al. [15]; J Hepatobiliary Pancreat Sci (82 HTLV-1-positive liver transplantation cohort during 1996 to 2013 data from multicenter study including 13 high-volume centers in Japan)
Donor negative, recipient positive, (N = 70) | Donor positive, recipient positive, (N = 6) | Donor positive, recipient negative, (N = 6) | Overall, (N = 82) | Risk factors by multivariate analysis | |
|---|---|---|---|---|---|
ATL development | N = 3 (4%) 432 days, 2107 days, 369 days | N = 2 (33%) 195 days (recipient-derived ATL) 1273 days (recipient-derived ATL) | N = 0 | N = 5 (6%) | Fulminant hematic failure (recipient status before transplantation) |
HAM development | N = 0 | N = 0 | N = 0 | N = 0 |